Viemed Q3 core revenue $35.8M, +28% YoY; ventilator patients up 11%

VIEMED HEALTHCARE, INC.

2022-Q3 EPS reported $0.09 revenue$101,324,000

Core net revenue of $35.8M for Q3 2022, a record, +28% YoY and +7% sequential.
Ventilator patient count 9,127, +11% YoY, highest growth since COVID-19 pandemic.
Adjusted EBITDA $7.0M in Q3, $20.7M YTD; reconciliation provided.
Repurchased 1.67M shares at $5.29 avg for $8.9M through Sep 30, 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VIEMED HEALTHCARE, INC. reported the quarter ended September 30, 2022 results: revenue $35.8 million.

Period: the quarter ended September 30, 2022
Revenue: $35.8 million
Result: reported results

Exact text from the filing

Net revenues attributable to the Company's core business for the quarter ended September 30, 2022 were $35.8 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VIEMED HEALTHCARE, INC. reported financial results for the nine months ended September 30, 2022.

Period: the nine months ended September 30, 2022
Result: reported results

Exact text from the filing

issued a press release announcing its financial results for the three and nine months ended September 30, 2022.

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-22-000098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.